Follow the 휴메딕스 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 휴메딕스 has logged 29 public disclosures. Market capitalisation: €272.6bn. The latest transaction was reported on 16 March 2026 (Other). Among the most active insiders: 배준규. All data is openly available.
29
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
4 ops.
Sell Volume
8Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 473 of 29,062 companies
84.9
score / 100
Value
93
Quality
76
FCF yld14%
Earn yld19%
EV/EBITDA3.7x
ROE7.3%
Gross mgn47%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.